
Sigli 1mg Tablet
Marketer
Siomond Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg)
Overview Sigli 1mg Tablet
Adults with type 2 diabetes mellitus may be prescribed Glibenclamide 1mg tablets, a sulfonylurea medication, to manage blood glucose levels. This helps mitigate serious diabetic complications like vision impairment and kidney disease. Glibenclamide 1mg may be used independently or in conjunction with other treatments. Administer just before or with the first meal, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continue Glibenclamide 1mg therapy as directed, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated blood glucose and increased risk of complications including neuropathy, renal damage, blindness, and limb loss. This medication is only one component of comprehensive diabetes management, which must include a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle adjustments are crucial for diabetes control. Common side effects include hypoglycemia (low blood sugar), nausea, headache, fatigue, and lightheadedness. Learn to identify hypoglycemia symptoms (sweating, dizziness, headache, tremors) and manage them accordingly. Maintain regular mealtimes and carry readily available glucose sources (e.g., sugary foods, fruit juice). Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Weight gain may occur. Do not use Glibenclamide 1mg if you have type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any prior heart, thyroid, or hormonal disorders before starting treatment, as it may be unsuitable. Pregnant or lactating individuals should consult their doctor. Regular blood glucose monitoring and blood tests (blood cell counts and liver function) will be necessary.
Primary Ingredients of Sigli 1mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Sigli 1mg Tablet
Managing type 2 diabetes
Major Benefits of Sigli 1mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sigli 1mg Tablet should be administered with a meal.
Common Side effects of Sigli 1mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use Sigli 1mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 1mg Sigli tablet should be taken with a meal.
How Sigli 1mg Tablet works:
One milligram Sigli tablets are used to treat diabetes. Their mechanism of action involves stimulating pancreatic insulin secretion, thereby reducing blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while taking Sigli 1mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Sigli 1mg Tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the benefits against potential risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Sigli 1mg Tablet while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Close monitoring of the nursing infant's blood sugar is recommended when the mother takes Sigli 1mg Tablet.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with impaired kidney function should use Sigli 1mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Sigli 1mg Tablets are contraindicated in patients with severe kidney disease due to the risk of severe, potentially prolonged hypoglycemia.
LiverCAUTION
Patients with liver impairment should use Sigli 1mg Tablet cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sigli 1mg Tablet is contraindicated in individuals with severe hepatic dysfunction due to the risk of severe hypoglycemia, which may resolve only after an extended period.
What if you forget to take Sigli 1mg Tablet :
Omit the missed Sigli 1mg Tablet dose and continue your regular dosing schedule.
Facts to Know About Sigli 1mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Third-generation sulfonylurea |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
